
|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
2
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
3
New sunscreen ingredient clears FDA for the first time since the 1990s
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5


